CBT vs. ABM vs. for Social Anxiety
Cognitive Behavior Therapy vs. Attention Bias Modification Treatment for Social Anxiety
1 other identifier
interventional
69
1 country
1
Brief Summary
Adults with Social Anxiety Disorder will be pseudo randomly assigned to either an individual cognitive behavior therapy, attention bias modification treatment (allocation ratio - 1.5:1). Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social anxiety disorder derived from structured clinical interviews based on Diagnostic and Statistical Manual (DSM) IV criteria. The investigators expect to find significant reduction in social anxiety symptoms in all of the groups, with the cognitive behavior therapy group showing greater reduction in symptoms than the other groups. Mechanisms of change in all of the groups will be examined via measures of cognitive biases, affect, and other common and specific factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 24, 2013
CompletedFirst Posted
Study publicly available on registry
July 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedFebruary 23, 2016
February 1, 2016
3.5 years
July 24, 2013
February 22, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Liebovitz Social Anxiety Scale (LSAS) - diagnostic interview
LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social situations. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance.
Expected time frame of up to 32 weeks per participant. Participants will be assessed before and after the administration of the treatment, every 4 weeks during treatment and at 3 months follow-up
Secondary Outcomes (1)
Social Phobia Inventory (SPIN) - self-report questionnaire
Up to 32 weeks per participant. The SPIN will be administered before and after each treatment session and at 3 months follow-up
Study Arms (2)
Attention Bias Modification (ABM)
EXPERIMENTALAttention training via 8 weekly repeated trials of a dot-probe task intended to direct attention away from threat stimuli.
Cognitive Behavior Therapy
EXPERIMENTALCBT will consist of 16-20 weekly individual treatment sessions aimed to reduce symptoms via cognitive and behavioral interventions
Interventions
Attention training via 8 weekly repeated trials of a dot-probe task intended to direct attention away from threat stimuli.
CBT will consist of 16-20 weekly individual treatment sessions aimed to reduce symptoms via cognitive and behavioral interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of Generalized Social Anxiety Disorder, LSAS\>50
- If on medication, patients must be on a stable dose
- Hebrew language fluency
You may not qualify if:
- Primary Axis I or Axis II disorder other than SAD
- suicidal ideation
- Substance dependence within the past three months or current substance abuse
- Mental retardation or another pervasive developmental disability
- Current or past schizophrenia or psychosis, current bipolar disorder, or organic brain syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hebrew University of Jerusalemlead
- Israel Science Foundationcollaborator
Study Sites (1)
The Hebrew University of Jerusalem
Jerusalem, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan D Huppert, PhD
Hebrew University of Jerusalem
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Psychology
Study Record Dates
First Submitted
July 24, 2013
First Posted
July 26, 2013
Study Start
January 1, 2011
Primary Completion
July 1, 2014
Study Completion
November 1, 2014
Last Updated
February 23, 2016
Record last verified: 2016-02